Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
vemurafenib is for oral use.
vemurafenib je určený na perorálne použitie.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cotellic + vemurafenib n=247
cotellic + vemurafenib n = 247
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
concurrent administration with vemurafenib
súbežné podávanie s vemurafenibom
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zelboraf 240 mg tablets vemurafenib
zelboraf 240 mg tablety vemurafenib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance is vemurafenib.
liečivo je vemurafenib.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cobimetinib plus vemurafenib (n = 247) (%)
kobimetinib plus vemurafenib (n = 247) (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
effects of concomitant medicines on vemurafenib
Účinky súbežne podávaných liekov na vemurafenib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vemurafenib is a moderate cyp1a2 inhibitor.
vemurafenib je stredne silný inhibítor cyp1a2.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
interaction of vemurafenib with drug transport systems
interakcia vemurafenibu s transportnými systémami liekov
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
effect of other medicinal products on vemurafenib
Účinky iných liekov na vemurafenib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
carcinogenicity studies have not been conducted with vemurafenib.
Štúdie karcinogenity s vemurafenibom sa neuskutočnili.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
6.2 months for the placebo plus vemurafenib arm.
6,2 mesiaca pre skupinu s placebom plus vemurafenibom.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cotellic treatment and vemurafenib treatment should be interrupted.
liečba cotellicom a liečba vemurafenibom sa má prerušiť.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dose modification of cotellic is independent of vemurafenib dose modification.
Úprava dávky cotellicu je nezávislá od úpravy dávky vemurafenibu.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cotellic in combination with vemurafenib in patients with brain metastases
cotellic v kombinácii s vemurafenibom u pacientov s metastázami v mozgu
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
accumulation occurs upon multiple twice daily dosing of vemurafenib.
po viacnásobnom dávkovaní vemurafenibu dvakrát denne sa objavila kumulácia.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cases of cuscc have been reported in patients treated with vemurafenib.
u pacientov liečených vemurafenibom sa zaznamenali prípady cuscc.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
discontinue permanently or interrupt vemurafenib treatment until grade 0 – 1.
trvalo ukončiť alebo prerušiť liečbu vemurafenibom až do 0 – 1. stupňa.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cotellic in combination with vemurafenib in patients who have progressed on a braf inhibitor
cotellic v kombinácii s vemurafenibom u pacientov, u ktorých došlo k progresii ochorenia počas liečby inhibítorom braf
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
all patients should be advised to avoid sun exposure while taking vemurafenib.
všetkým pacientom sa má odporučiť, aby sa počas užívania vemurafenibu vyhýbali expozícii slnka.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: